Press release
Gene Therapy Market Size to Cross $16.5 Billion by 2035 | Exclusive Report by Roots Analysis
The global gene therapy market size was valued at USD 2.4 billion in 2024 and likely to cross over USD 16.5 billion by 2035, growing at a CAGR of 19.25% during the forecast period 2024 to 2035Gene therapies are a class of biologic products designed to alter the genetic material of an individual to treat rare diseases caused by inherited genetic mutations. These therapies are developed to address the underlying genetic cause of a disease, either by introducing a healthy version of the mutated gene or by inactivating the functions of disease-causing genes within the body. Currently, 20 gene therapies are commercially available for the treatment of various genetic disorders, including spinal muscular atrophy and sickle cell disease. Additionally, more than 370 candidates are currently being evaluated across various phases of clinical trials and around 920 gene therapies are being developed across preclinical and discovery stages of development. Further, it is worth highlighting that these therapies have demonstrated tremendous potential in revolutionizing the treatment of chronic conditions, with promising results in achieving complete disease remission. As such, the demand for gene therapies is increasing substantially, thereby encouraging gene therapy companies and non-industry players to enhance their R&D capabilities in order to develop and advance a greater number of therapies towards the commercial market. Driven by the growing demand for targeted therapies, the gene therapy market size is poised to experience a noteworthy increase during the forecast period.
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/gene-therapy-market-3rd-edition-2019-2030/request-sample.html
By Therapeutic Area, muscle disorders are anticipated to capture the largest share of the global gene therapy market
1. The muscle disorders segment captures the largest revenue share of more than 70% in the gene therapy market, in 2024.
2. The cardiovascular disorders segment is anticipated to witness the highest market growth rate of 47.98%, during the forecast period.
By Type of Vector, Adeno-associated virus vector is anticipated to capture the largest share of the global gene therapy market
1. Adeno-associated virus vectors segment captures the largest revenue share of close to 80% in the gene therapy market, in 2024.
2. Non-viral vectors segment is anticipated to be the fastest growing segment in gene therapy market with a CAGR of 73.26%, during the forecast period.
By Type of Therapy, Gene Augmentation are anticipated to capture the largest share of the global gene therapy market
1. The gene augmentation segment captures the largest revenue share of 94% in the gene therapy market, in 2024.
2. The gene regulation segment is anticipated to witness a higher CAGR of 53.10%, during the forecast period.
By Type of Gene Delivery Method, In vivo gene delivery segment is anticipated to capture the largest share of the global gene therapy market
1. The in vivo gene delivery segment captures the largest revenue share of 91% in the gene therapy market, in 2024.
2. The ex vivo gene delivery segment is anticipated to witness the highest market growth rate of 30.67%, during the forecast period.
By Route of Administration, intravenous segment is anticipated to capture the largest share of the global gene therapy market
1. The intravenous route segment captures the largest revenue share of close to 85% in the gene therapy market, in 2024.
2. The intramuscular route segment is anticipated to witness a higher market growth rate of 31.98%, during the forecast period.
To request quote of this report, please visit
https://www.rootsanalysis.com/reports/gene-therapy-market-3rd-edition-2019-2030/request-quote.html
Gene Therapy Market - Regional Analysis
1. North America dominates the gene therapy market and accounts for the largest revenue share of more than 60% in 2024.
2. In Europe, the gene therapy market is anticipated to witness a higher growth rate of 20.79%, during the forecast period.
Key Companies Profiled
The gene therapy market report also includes profiles of key players (listed below) that are involved in the development of gene therapies:
1. Amgen
2. Artgen Biotech
3. BioMarin Pharmaceutical
4. bluebird bio
5. CRISPR Therapeutics
6. CSL Behring
7. Ferring Pharmaceuticals
8. Kolon TissueGene
9. Krystal Biotech
10. Novartis
11. Orchard Therapeutics
12. Pfizer
13. PTC Therapeutics
14. Sarepta Therapeutics
15. Shanghai Sunway Biotech
16. Sibiono GeneTech
17. Spark Therapeutics
Gene Therapy Market - Key Segments
Gene Therapy Market, by Therapeutic Area
1. Cardiovascular Disorders
2. Dermatological Disorders
3. Genetic Disorders
4. Hematological Disorders
5. Metabolic Disorders
6. Muscle Disorders
7. Oncological Disorders
8. Ophthalmic Disorders
9. Other Disorders
Gene Therapy Market, by Type of Vector
1. Adeno-Associated Virus Vectors
2. Adenovirus Vectors
3. Herpes Simplex Virus Vectors
4. Lentivirus Vectors
5. Non-Viral Vectors
6. Retroviral Vectors
7. Other Vectors
Gene Therapy Market, by Type of Therapy
1. Gene Augmentation
2. Gene Editing
3. Gene Regulation
4. Oncolytic Immunotherapy
5. Other Therapies
Gene Therapy Market, by Type of Gene Delivery Method
1. In vivo
2. Ex vivo
Gene Therapy Market, by Route of Administration
1. Intramuscular Route
2. Intratumoral Route
3. Intravenous Route
4. Subretinal Route
5. Other Routes of Administration
Gene Therapy Market, by Geographical Region
1. North America
2. Europe
3. Asia
4. Latin America
5. Rest of the World
Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/gene-therapies-market/268.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Therapy Market Size to Cross $16.5 Billion by 2035 | Exclusive Report by Roots Analysis here
News-ID: 3902091 • Views: …
More Releases from Roots Analysis
Gene switches have garnered significant attention from drug developers owing to …
The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035.
Driven by numerous developmental breakthroughs and encouraging study results demonstrating the vast potential of adoptive cell therapies (ACT), including CAR-T cell therapies, TCR therapies, TILs and natural killer cell therapies, in the treatment of various complex disorders, this…
Antibody Discovery Market Set to Soar to $6.6 Billion by 2035
Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules (antigens) that enter the body. The term antigen refers to any substance that is capable of inducing an immune response, encompassing a diverse range of entities, including viruses, fungi, bacteria, proteins on the surface of cells, and non-living substances, such as toxins, chemicals and foreign particles.
The global antibody discovery…
Biopsy is defined as a procedure of removing or extracting tissue from the body …
The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.
This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue,…
Big data in healthcare: transforms patient care, enhances efficiency, and unlock …
The global big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% during the forecast period till 2035. Big data in healthcare is the collection of large amounts of unstructured data from various sources, such as medical research, biometric data, electronic medical records, Internet of Medical Things (IoMT), social media, payer records, omics…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
